Zhijun Zhou

5PUBLICATIONS
27CO-AUTHORS
ChemotherapyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 27, 2026
Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer.

|Jul 22, 2025
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy.

Zhijun Zhou, Yang Cai, Hao Yuan

|Dec 14, 2022
EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.

Tianfu Yu, Fengqi Zhou, Wei Tian

|Aug 13, 2021
MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer.

Qiangsheng Hu, Yi Qin, Shunrong Ji

|Jun 27, 2021
Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways.

Zhen Xiang, Zhijun Zhou, Shuzheng Song

Pageof 1

Frequent Collaborators

4 joint publications

Min Li

2 joint publications

Jingxuan Yang

2 joint publications

Hao Yuan

2 joint publications

Courtney W Houchen